Galderma to Pursue a Scientific Partnership with L’Oréal

Galderma has signed a memorandum of understanding with L’Oréal to work toward a new research and development (R&D) collaboration in the form of a scientific partnership, according to a company news release. The partnership would focus on complementary research projects, which the companies say could develop advanced, future-proof technologies with direct applications in the field of dermatology.

"Today’s announcement enables Galderma and L’Oréal to pursue new avenues and accelerate innovation in the field of dermatology in order to deliver new combined levels of performance against the signs of skin aging. It can ultimately enable these two leaders to jointly develop new products using complementary technology to expand and enhance their respective product portfolios," Galderma stated in a news release.

"We are delighted to welcome L’Oréal as a new, long-term Galderma shareholder and see their investment as a sign of confidence in our strategy, track record and growth potential. We look forward to pursuing scientific partnership opportunities together, for the benefit of the customers, patients and consumers we serve across the globe every day," Flemming Ørnskov, MD, MPH, chief executive officer, Galderma, said in the news release.